MedPage Today November 7, 2024
— Is price negotiation in the next administration’s crosshairs or is it “political suicide”?
In 2022, the Biden administration passed the Inflation Reduction Act (IRA), which allowed Medicare to negotiate prescription drug prices for the first time — a reform long sought by progressive Democrats. Under President-elect Trump, the future of the program is less certain.
But if there’s one thing that experts agree on, it’s that whole-cloth repeal of the law won’t be easy.
“I don’t think there’s any upside to Republicans saying they’re going to repeal the IRA, because that means repealing the cap on out-of-pocket [costs], and that is political suicide,” said Douglas Holtz-Eakin, PhD, president of the American Action Forum, a conservative think tank, referring to...
Today's Sponsors
Today's Sponsor